FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972080883> ?p ?o ?g. }

• W1972080883 endingPage "1195" @default.
• W1972080883 startingPage "1184" @default.
• W1972080883 abstract "We assessed metabolic changes for darunavir/ritonavir (DRV/r) once daily (qd) versus atazanavir/ritonavir (ATV/r) qd with fixed-dose tenofovir/emtricitabine. This was a phase 4, multicenter, open-label, randomized exploratory study. Treatment-naive, HIV-1-infected adults received DRV/r 800/100 mg qd or ATV/r 300/100 mg qd, both with emtricitabine/tenofovir 200/300 mg qd. Primary end point: change in triglyceride levels from baseline to week 12. Secondary end points: week 12 and week 48 changes in lipid parameters, insulin sensitivity, inflammatory/coagulation/bacterial translocation biomarkers, viral load, CD4+ cell count, and week 48 changes in adipose tissue distribution and subjects' perceptions of body changes. In the DRV/r arm, 32/34 and 29/34 subjects completed weeks 12 and 48, respectively; in the ATV/r arm, 30/31 and 25/31 subjects completed weeks 12 and 48, respectively. Small changes in lipid parameters from baseline to weeks 12 and 48 were observed in both arms. Differences were noted between arms in mean changes in total cholesterol (DRV/r, 20.3 mg/dl; ATV/r, 4.6 mg/dl) and apolipoprotein A1 (DRV/r, 10.7 mg/dl; ATV/r, –0.7 mg/dl) at week 12. At week 48, no clinically relevant differences between arms were noted for changes in any lipid parameter, fasting glucose, or insulin sensitivity. Biomarkers generally decreased and efficacy parameters improved in both arms over 48 weeks. Changes in adipose tissue were small and comparable between arms. Subjects' perceptions of body changes generally improved in both study arms. This first pilot comparison in HIV-1-infected subjects suggests that DRV/r has a metabolic profile similar to ATV/r over 48 weeks of treatment. Further randomized studies are warranted." @default.
• W1972080883 created "2016-06-24" @default.
• W1972080883 creator A5000473129 @default.
• W1972080883 creator A5013736817 @default.
• W1972080883 creator A5016102389 @default.
• W1972080883 creator A5027057125 @default.
• W1972080883 creator A5040749778 @default.
• W1972080883 creator A5061630637 @default.
• W1972080883 creator A5072449563 @default.
• W1972080883 creator A5081237345 @default.
• W1972080883 creator A5088973456 @default.
• W1972080883 date "2012-10-01" @default.
• W1972080883 modified "2023-10-16" @default.
• W1972080883 title "Metabolic Effects of Darunavir/Ritonavir Versus Atazanavir/Ritonavir in Treatment-Naive, HIV Type 1-Infected Subjects over 48 Weeks" @default.
• W1972080883 cites W1588263000 @default.
• W1972080883 cites W1767400858 @default.
• W1972080883 cites W1977705956 @default.
• W1972080883 cites W1979192842 @default.
• W1972080883 cites W1982280354 @default.
• W1972080883 cites W1984717040 @default.
• W1972080883 cites W1987426931 @default.
• W1972080883 cites W2002147948 @default.
• W1972080883 cites W2007142745 @default.
• W1972080883 cites W2015990374 @default.
• W1972080883 cites W2016336666 @default.
• W1972080883 cites W2019724673 @default.
• W1972080883 cites W2020054062 @default.
• W1972080883 cites W2020188047 @default.
• W1972080883 cites W2032539027 @default.
• W1972080883 cites W2033756224 @default.
• W1972080883 cites W2035781049 @default.
• W1972080883 cites W2044377869 @default.
• W1972080883 cites W2049969210 @default.
• W1972080883 cites W2050293562 @default.
• W1972080883 cites W2050596201 @default.
• W1972080883 cites W2052412767 @default.
• W1972080883 cites W2053382469 @default.
• W1972080883 cites W2059473808 @default.
• W1972080883 cites W2059836477 @default.
• W1972080883 cites W2060139450 @default.
• W1972080883 cites W2067230484 @default.
• W1972080883 cites W2068355743 @default.
• W1972080883 cites W2073738273 @default.
• W1972080883 cites W2076339980 @default.
• W1972080883 cites W2080152031 @default.
• W1972080883 cites W2083751424 @default.
• W1972080883 cites W2100285658 @default.
• W1972080883 cites W2102679591 @default.
• W1972080883 cites W2105343975 @default.
• W1972080883 cites W2108511310 @default.
• W1972080883 cites W2111064211 @default.
• W1972080883 cites W2113145901 @default.
• W1972080883 cites W2117151275 @default.
• W1972080883 cites W2122483069 @default.
• W1972080883 cites W2127517680 @default.
• W1972080883 cites W2136385005 @default.
• W1972080883 cites W2136784795 @default.
• W1972080883 cites W2140056361 @default.
• W1972080883 cites W2141776462 @default.
• W1972080883 cites W2152868796 @default.
• W1972080883 cites W2158757291 @default.
• W1972080883 cites W2160234571 @default.
• W1972080883 cites W2161139221 @default.
• W1972080883 cites W2167709851 @default.
• W1972080883 cites W2170241744 @default.
• W1972080883 cites W2359259550 @default.
• W1972080883 doi "https://doi.org/10.1089/aid.2011.0327" @default.
• W1972080883 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3448095" @default.
• W1972080883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22352336" @default.
• W1972080883 hasPublicationYear "2012" @default.
• W1972080883 type Work @default.
• W1972080883 sameAs 1972080883 @default.
• W1972080883 citedByCount "74" @default.
• W1972080883 countsByYear W19720808832013 @default.
• W1972080883 countsByYear W19720808832014 @default.
• W1972080883 countsByYear W19720808832015 @default.
• W1972080883 countsByYear W19720808832016 @default.
• W1972080883 countsByYear W19720808832017 @default.
• W1972080883 countsByYear W19720808832018 @default.
• W1972080883 countsByYear W19720808832019 @default.
• W1972080883 countsByYear W19720808832020 @default.
• W1972080883 countsByYear W19720808832021 @default.
• W1972080883 countsByYear W19720808832022 @default.
• W1972080883 crossrefType "journal-article" @default.
• W1972080883 hasAuthorship W1972080883A5000473129 @default.
• W1972080883 hasAuthorship W1972080883A5013736817 @default.
• W1972080883 hasAuthorship W1972080883A5016102389 @default.
• W1972080883 hasAuthorship W1972080883A5027057125 @default.
• W1972080883 hasAuthorship W1972080883A5040749778 @default.
• W1972080883 hasAuthorship W1972080883A5061630637 @default.
• W1972080883 hasAuthorship W1972080883A5072449563 @default.
• W1972080883 hasAuthorship W1972080883A5081237345 @default.
• W1972080883 hasAuthorship W1972080883A5088973456 @default.
• W1972080883 hasBestOaLocation W19720808832 @default.
• W1972080883 hasConcept C126322002 @default.
• W1972080883 hasConcept C134018914 @default.
• W1972080883 hasConcept C142462285 @default.
• W1972080883 hasConcept C203014093 @default.

• next